{"title":"晚期胰腺癌:近几十年来的诊断和系统治疗进展","authors":"Ireneusz Raczyński, J. Didkowska, B. Radecka","doi":"10.5603/ocp.2022.0030","DOIUrl":null,"url":null,"abstract":"Pancreatic cancer is one of common malignant neoplasms. It is characterised by poor prognosis and high mortality, which is mainly due to detection in advanced stage. The review presents the epidemiological and clinical characteristics of pancreatic cancer as well as current strategies of systemic treatment of advanced disease, including firstand second-line chemotherapy as well as molecularly targeted therapies and immunotherapy.","PeriodicalId":42942,"journal":{"name":"Oncology in Clinical Practice","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advanced pancreatic cancer: diagnosis and systemic treatment evolution over the last decades\",\"authors\":\"Ireneusz Raczyński, J. Didkowska, B. Radecka\",\"doi\":\"10.5603/ocp.2022.0030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pancreatic cancer is one of common malignant neoplasms. It is characterised by poor prognosis and high mortality, which is mainly due to detection in advanced stage. The review presents the epidemiological and clinical characteristics of pancreatic cancer as well as current strategies of systemic treatment of advanced disease, including firstand second-line chemotherapy as well as molecularly targeted therapies and immunotherapy.\",\"PeriodicalId\":42942,\"journal\":{\"name\":\"Oncology in Clinical Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology in Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/ocp.2022.0030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ocp.2022.0030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Advanced pancreatic cancer: diagnosis and systemic treatment evolution over the last decades
Pancreatic cancer is one of common malignant neoplasms. It is characterised by poor prognosis and high mortality, which is mainly due to detection in advanced stage. The review presents the epidemiological and clinical characteristics of pancreatic cancer as well as current strategies of systemic treatment of advanced disease, including firstand second-line chemotherapy as well as molecularly targeted therapies and immunotherapy.